J P Gisbert

Summary

Country: Spain

Publications

  1. ncbi Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    Aliment Pharmacol Ther 28:228-38. 2008
  2. doi [Rescue therapy after Helicobacter pylori eradication failure]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Espana
    Gastroenterol Hepatol 34:89-99. 2011
  3. ncbi The sequential therapy regimen for Helicobacter pylori eradication
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, 62 Diego de Leon, 28006 Madrid, Spain
    Expert Opin Pharmacother 11:905-18. 2010
  4. ncbi Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs
    J P Gisbert
    Dept of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Scand J Gastroenterol 36:717-24. 2001
  5. ncbi [Treatment of stenosis due to Crohn's disease]
    J P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de La Princesa Madrid Spain
    Gastroenterol Hepatol 25:560-9. 2002
  6. ncbi [Thiopurine methyltransferase activity in patients with autoimmune hepatitis]
    Javier P Gisbert
    Servicio de Gastroenterología y Hepatología Hospital Universitario de la Princesa Universidad Autónoma Madrid Spain
    Med Clin (Barc) 121:481-4. 2003
  7. ncbi [Treatment of alcoholic hepatitis with corticosteroids. Are they really effective?]
    Javier P Gisbert
    Servicio de Gastroenterología y Hepatología Hospital Universtiario de la Princesa Madrid España
    Med Clin (Barc) 119:590-5. 2002
  8. ncbi One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication
    J P Gisbert
    Department of Gastroenterology, Hospital de la Princessa, Universidad Autonoma de Madrid, Spain
    Eur J Gastroenterol Hepatol 12:489-95. 2000
  9. ncbi Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures
    J P Gisbert
    Department of Gastroenterology, La Princesa University Hospital, Universidad Autonoma, Madrid, Spain
    Aliment Pharmacol Ther 24:1469-74. 2006
  10. ncbi [Breath tests in the diagnosis of gastrointestinal diseases]
    J P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Espana
    Gastroenterol Hepatol 28:407-16. 2005

Detail Information

Publications160 found, 100 shown here

  1. ncbi Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    Aliment Pharmacol Ther 28:228-38. 2008
    ..The long-term efficiacy for thiopurinic drugs in Crohn's disease (CD), and particularly in ulcerative colitis (UC), has been insufficiently studied...
  2. doi [Rescue therapy after Helicobacter pylori eradication failure]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Espana
    Gastroenterol Hepatol 34:89-99. 2011
    ..Finally, rifabutin-based therapies have achieved promising results and are even effective in patients with multiple failures or multiple antibiotic resistance...
  3. ncbi The sequential therapy regimen for Helicobacter pylori eradication
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, 62 Diego de Leon, 28006 Madrid, Spain
    Expert Opin Pharmacother 11:905-18. 2010
    ..Standard triple therapy (STT) is the most used treatment for Helicobater pylori infection. The prevalence of antibiotic resistance has increased substantially in recent years and there has been a corresponding decrease in efficacy...
  4. ncbi Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs
    J P Gisbert
    Dept of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Scand J Gastroenterol 36:717-24. 2001
    ..Our aim was to study the prevalence of H. pylori in bleeding duodenal ulcer (DU), with both invasive and non-invasive methods, and to assess the role of non-steroidal anti-inflammatory drugs (NSAIDs)...
  5. ncbi [Treatment of stenosis due to Crohn's disease]
    J P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de La Princesa Madrid Spain
    Gastroenterol Hepatol 25:560-9. 2002
  6. ncbi [Thiopurine methyltransferase activity in patients with autoimmune hepatitis]
    Javier P Gisbert
    Servicio de Gastroenterología y Hepatología Hospital Universitario de la Princesa Universidad Autónoma Madrid Spain
    Med Clin (Barc) 121:481-4. 2003
    ..Our objective was to analyze the activity of TPMT in a group of 200 patients with autoimmune hepatitis and to evaluate the possible effect of some variables such as the treatment with azathioprine on this activity...
  7. ncbi [Treatment of alcoholic hepatitis with corticosteroids. Are they really effective?]
    Javier P Gisbert
    Servicio de Gastroenterología y Hepatología Hospital Universtiario de la Princesa Madrid España
    Med Clin (Barc) 119:590-5. 2002
  8. ncbi One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication
    J P Gisbert
    Department of Gastroenterology, Hospital de la Princessa, Universidad Autonoma de Madrid, Spain
    Eur J Gastroenterol Hepatol 12:489-95. 2000
    ..Our aim was to evaluate and to compare these two novel short-term triple therapies (Pan+Amo+Cla and RBC+Amo+Cla) for treatment of Helicobacter pylori...
  9. ncbi Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures
    J P Gisbert
    Department of Gastroenterology, La Princesa University Hospital, Universidad Autonoma, Madrid, Spain
    Aliment Pharmacol Ther 24:1469-74. 2006
    ..In patients with a first eradication failure, a second (rescue) therapy still fails in > 20% of cases...
  10. ncbi [Breath tests in the diagnosis of gastrointestinal diseases]
    J P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Espana
    Gastroenterol Hepatol 28:407-16. 2005
    ....
  11. ncbi Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Madrid, Spain
    Am J Gastroenterol 104:760-7. 2009
    ..To review the frequency with which infliximabloses its effect and dose "intensification" is required for Crohn's disease treatment...
  12. ncbi Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication
    J P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain
    Aliment Pharmacol Ther 17:751-64. 2003
    ....
  13. ncbi Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments
    J P Gisbert
    Department of Gastroenterology, La Princesa University Hospital, Madrid, Spain
    Dig Liver Dis 36:7-12. 2004
    ..pylori in approximately 20-30% of the cases. Our aim was to evaluate the efficacy of different rescue therapies prescribed to patients in whom two consecutive H. pylori eradication regimens had failed...
  14. ncbi Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis
    Javier P Gisbert
    Gastroenterology and Hepatology Service, La Princesa University Hospital, Madrid, Spain
    Gastroenterology 125:1723-32. 2003
    ....
  15. ncbi 13C-urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding
    Javier P Gisbert
    Service of Gastroenterology and Hepatology, La Princesa University Hospital, Universidad Autonoma, Madrid, Spain
    Helicobacter 12:231-7. 2007
    ..To evaluate the accuracy of (13)C-urea breath test (UBT) to detect Helicobacter pylori infection in patients hospitalized with peptic ulcer bleeding and treated with proton pump inhibitors (PPIs)...
  16. ncbi Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists--their efficacy with antibiotics in Helicobacter pylori eradication
    J P Gisbert
    Department of Gastroenterology, University Hospital, Madrid, Spain
    Aliment Pharmacol Ther 18:757-66. 2003
    ..It is unknown whether proton pump inhibitors are superior to H2-receptor antagonists in Helicobacter pylori eradication regimens...
  17. doi Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement
    Javier P Gisbert
    Hospital Universitario de la Princesa, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Madrid, Spain
    Inflamm Bowel Dis 15:1485-91. 2009
    ..The aim was to evaluate the efficacy and tolerance of oral and intravenous iron treatment in anemic inflammatory bowel disease (IBD) patients, considering both hematological and quality-of-life outcomes...
  18. ncbi [Indications and consequences of Helicobacter pylori eradication on gastroesophageal reflux disease]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Espana
    Med Clin (Barc) 124:697-709. 2005
    ..In the meantime, as it occurs with any controversial indication, the decision of the doctor facing a patient infected by H. pylori and needing maintenance therapy with PPIs should be assessed on a case by case basis...
  19. ncbi Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication
    Javier P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Helicobacter 10:157-71. 2005
    ..RBC with two antibiotics for 1 week...
  20. ncbi Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Universidad Autonoma, Madrid, Spain
    Hepatogastroenterology 53:399-404. 2006
    ..To prospectively evaluate whether, in patients with inflammatory bowel disease, the choice of azathioprine (AZA) or 6-mercaptopurine (6-MP) dose based on thiopurine methyltransferase (TPMT) activity prevents myelotoxicity...
  21. ncbi Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Instituto de Investigación Sanitaria Princesa IP, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Madrid, Spain
    Scand J Gastroenterol 48:652-6. 2013
    ..Eradication with rescue regimens may be challenging after failure of key antibiotics such as clarithromycin and nitroimidazoles...
  22. ncbi Gastric MALT lymphoma: clinical characteristics and prevalence of H. pylori infection in a series of 37 cases
    J P Gisbert
    Servides of Gastroenterology, Hospital Universitario de La Princesa Universidad Autónoma Madrid, Spain
    Rev Esp Enferm Dig 98:655-65. 2006
    ..to perform a retrospective review of the clinical characteristics and prevalence of H. pylori infection in patients with gastric MALT lymphoma diagnosed in our hospital during the last 15 years...
  23. ncbi Evaluation of 3 different tests for the detection of stool antigens to confirm Helicobacter pylori eradication after treatment. A pilot study
    J P Gisbert
    Servicio de Gastroenterologia, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain
    Gastroenterol Hepatol 28:615-8. 2005
    ..Recently, several new diagnostic methods aimed to detect Helicobacter pylori stool antigens have been developed. Our aim was to evaluate the accuracy of 3 different stool tests to confirm H. pylori eradication...
  24. ncbi Helicobacter pylori therapy: first-line options and rescue regimen
    J P Gisbert
    Department of Gastroenterology, University Hospital La Princesa, Madrid, Spain
    Dig Dis 19:134-43. 2001
    ....
  25. ncbi Helicobacter pylori and gastroesophageal reflux disease: lack of influence of infection on twenty-four-hour esophageal pH monitoring and endoscopic findings
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    J Clin Gastroenterol 32:210-4. 2001
    ..14 +/- 12 mmHg) among H. pylori-positive and -negative patients. H. pylori infection is not associated with gastroesophageal reflux disease, as evaluated endoscopically and with 24-hour esophageal pH monitoring...
  26. ncbi [Common errors in the management of outpatients with inflammatory bowel disease]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Universidad Autonoma, Madrid, Espana
    Gastroenterol Hepatol 30:469-86. 2007
  27. ncbi Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review
    Javier P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Helicobacter 9:347-68. 2004
    ..Sensitivity and/or specificity in patients with gastrointestinal bleeding may be suboptimal. The stool antigen test performs well in children. Finally, the stool antigen test seems to be a cost-effective method...
  28. ncbi Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Universidad Autonoma, Madrid, Spain
    Inflamm Bowel Dis 13:1106-14. 2007
    ....
  29. ncbi [How can we find, design, evaluate and use clinical practice guidelines?]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain
    Gastroenterol Hepatol 31:239-57. 2008
  30. ncbi [Thiopurine methyltransferase activity in inflammatory bowel disease. A study on 7046 Spanish patients]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Universidad Autonoma, Madrid, Spain
    Med Clin (Barc) 125:281-5. 2005
    ....
  31. ncbi Long-term follow-up of 13C-urea breath test results after Helicobacter pylori eradication: frequency and significance of borderline delta13CO2 values
    J P Gisbert
    Gastroenterology Unit, La Princesa University Hospital, Autonomous University, Madrid, Spain
    Aliment Pharmacol Ther 23:275-80. 2006
    ..The precise choice of cut-off point for the 13C-urea breath test to define whether it is positive or negative represents a controversial issue...
  32. ncbi 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Universidad Autonoma, Madrid, Spain
    Inflamm Bowel Dis 13:629-38. 2007
    ..The optimal monitoring schedule of serum creatinine in patients receiving 5-ASA treatment remains to be established, as there is no evidence to date that either the test, or the frequency of testing, improves patient outcomes...
  33. ncbi Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection
    J P Gisbert
    Gastroenterology and Hepatology Service, La Princesa University Hospital, 28006 Madrid, Spain
    Aliment Pharmacol Ther 21:653-62. 2005
    ....
  34. ncbi Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure
    Javier P Gisbert
    Department of Gastroenterology, La Princesa University Hospital, Universidad Autonoma, Madrid, Spain
    Helicobacter 12:68-73. 2007
    ..Our aim was to compare two 7-day triple second-line regimens containing ranitidine bismuth citrate or levofloxacin...
  35. ncbi First-line triple therapy with levofloxacin for Helicobacter pylori eradication
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Madrid, Spain
    Aliment Pharmacol Ther 26:495-500. 2007
    ..At present, the efficacy of proton pump inhibitor-clarithromycin-amoxicillin regimen is relatively low...
  36. ncbi How effective are rescue H. pylori eradication therapies in patients with dyspepsia?
    Javier P Gisbert
    Gastroenterololgy Unit, La Princesa University Hospital, Madrid, Spain
    Nat Clin Pract Gastroenterol Hepatol 2:180-1. 2005
  37. ncbi Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Aliment Pharmacol Ther 20:1001-17. 2004
    ....
  38. ncbi The prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma
    Javier P Gisbert
    Gastroenterology and Hepatology Service, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Spain
    Eur J Gastroenterol Hepatol 16:135-8. 2004
    ..The aim of the present study was to assess the prevalence of hepatitis C virus (HCV) infection among patients with non-Hodgkin's lymphoma (NHL), and to compare it with that of a control group of voluntary blood donors...
  39. ncbi Evaluation of three different tests for the detection of stool antigens to diagnose Helicobacter pylori infection in patients with upper gastrointestinal bleeding
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Spain
    Aliment Pharmacol Ther 19:923-9. 2004
    ..To evaluate the accuracy of several methods aimed to detect Helicobacter pylori stool antigens in patients with upper gastrointestinal bleeding...
  40. ncbi Thiopurine methyltransferase activity in Spain: a study of 14,545 patients
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Universidad Autonoma, Playa de Mojácar 29, Urb, Bonanza, 28669, Boadilla del Monte, Madrid, Spain
    Dig Dis Sci 52:1262-9. 2007
    ....
  41. doi Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    Dig Liver Dis 41:56-66. 2009
    ..Greater faecal calprotectin concentration has been shown in asymptomatic first-degree relatives of patients with inflammatory bowel disease, suggesting that there is a high prevalence of subclinical intestinal inflammation in them...
  42. ncbi Hepatocellular carcinoma risk in patients with porphyria cutanea tarda
    Javier P Gisbert
    Gastroenterology and Hepatology Service, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Spain
    Eur J Gastroenterol Hepatol 16:689-92. 2004
    ..The aim of our study was to evaluate the incidence of HCC in patients with PCT, and to assess the possible co-factors associated with cancer development...
  43. ncbi Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Spain
    Aliment Pharmacol Ther 19:617-29. 2004
    ..To perform a meta-analysis comparing the efficacy of Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer...
  44. ncbi Kinetics of anti-hepatitis B surface antigen titers after hepatitis B vaccination in patients with inflammatory bowel disease
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain
    Inflamm Bowel Dis 19:554-8. 2013
    ....
  45. ncbi [Helicobacter pylori infection and functional dyspepsia. Meta-analysis of efficacy of eradication therapy]
    Javier P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de La Princesa Madrid Spain
    Med Clin (Barc) 118:405-9. 2002
    ..Our aim was to perform a meta-analysis of randomized studies comparing, in functional dyspepsia, the efficacy of H. pylori eradication treatment with that of treatments with no effect on H. pylori infection...
  46. ncbi [Stool antigen test for initial Helicobacter pylori diagnosis and for confirmation of eradication after therapy]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa Madrid Spain
    Med Clin (Barc) 118:401-4. 2002
    ..Our aim was to prospectively evaluate the accuracy of HpSA both in the initial diagnosis of H. pylori infection and in the confirmation of the eradication after treatment...
  47. ncbi Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients
    Javier P Gisbert
    Gastroenterology Unit, La Princesa, Instituto de Investigación Sanitaria Princesa IP y, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Madrid, Spain
    J Clin Gastroenterol 47:130-5. 2013
    ..Second-line bismuth-containing quadruple therapy is complex and frequently induces adverse effects. A triple rescue regimen containing levofloxacin is a potential alternative; however, resistance to quinolones is rapidly increasing...
  48. ncbi Helicobacter pylori "test-and-scope" strategy for dyspeptic patients. Is it useful and safe?
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Dig Liver Dis 33:539-45. 2001
    ..To evaluate outcome of test-and-scope strategy using 13C-urea breath test, Helicobacter pylori IgG serology, and CagA serology...
  49. doi Review article: rifabutin in the treatment of refractory Helicobacter pylori infection
    J P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain
    Aliment Pharmacol Ther 35:209-21. 2012
    ..Even with the current most effective treatment regimens, a relevant proportion of patients will fail to eradicate Helicobacter pylori infection...
  50. ncbi Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures
    J P Gisbert
    Gastroenterology Department, Hospital de la Princesa, Madrid, Spain
    Aliment Pharmacol Ther 35:941-7. 2012
    ..In some cases, Helicobacter pylori infection persists even after three eradication treatments...
  51. doi Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease
    J P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain
    Aliment Pharmacol Ther 35:1379-85. 2012
    ..The response rate to hepatitis B virus (HBV) vaccination in patients with inflammatory bowel disease (IBD) is low...
  52. ncbi Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Aliment Pharmacol Ther 14:1319-28. 2000
    ..those using proton pump inhibitor, clarithromycin and a nitroimidazole (N) (PCN) for H. pylori eradication...
  53. doi Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease
    J P Gisbert
    Department of Gastroenterology and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain
    Am J Gastroenterol 107:1460-6. 2012
    ....
  54. ncbi 13C-urea breath test for the diagnosis of Helicobacter pylori infection before treatment: is citric acid necessary?
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Dig Liver Dis 32:20-4. 2000
    ..Thus, our aim was to compare 13C-urea breath test with and without citric acid solution, to evaluate whether 13C-urea breath test can also achieve favourable results when the test meal is omitted...
  55. ncbi Value of quantitative serology for confirmation of Helicobacter pylori eradication: an 18-month follow-up study
    J P Gisbert
    Department of Gastroenterology, Hospital de la Princesa, Universidad Autonoma, Madrid, Spain
    Clin Infect Dis 30:976-80. 2000
    ..5 months after antibiotic therapy is completed) can be used as a noninvasive, simple, and inexpensive method to confirm H. pylori eradication...
  56. doi Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
    J P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, and Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas CIBERehd, Madrid, Spain
    Aliment Pharmacol Ther 34:604-17. 2011
    ..Traditional standard triple therapy for Helicobacter pylori infection (PPI-clarithromycin-amoxicillin) can easily be converted to non-bismuth quadruple (concomitant) therapy by the addition of a nitroimidazole twice daily...
  57. ncbi Review article: Helicobacter pylori infection and gastric outlet obstruction - prevalence of the infection and role of antimicrobial treatment
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Aliment Pharmacol Ther 16:1203-8. 2002
    ..pylori-positive stenosis, whereas dilation or surgery should be reserved for patients who do not respond to such medical therapy...
  58. doi Review article: Helicobacter pylori-negative duodenal ulcer disease
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD m, Madrid, Spain
    Aliment Pharmacol Ther 30:791-815. 2009
    ..Helicobacter pylori infection rates in duodenal ulcer (DU) patients may be lower than previously estimated...
  59. ncbi Effect of 5-aminosalicylates on renal function in patients with inflammatory bowel disease: 4-year follow-up study
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    Gastroenterol Hepatol 31:477-84. 2008
    ..Our aim was to conduct a retrospective study of IBD patients, both with and without 5-ASA treatment, who underwent regular evaluation of renal function over a 4-year period...
  60. pmc Rescue Therapy for Helicobacter pylori Infection 2012
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, and Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas CIBERehd, 28006 Madrid, Spain
    Gastroenterol Res Pract 2012:974594. 2012
    ..Even after two consecutive failures, several studies have demonstrated that H. pylori eradication can finally be achieved in almost all patients if several "rescue" therapies are consecutively given...
  61. pmc Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, and Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas CIBERehd, Madrid, Spain
    Clin Exp Gastroenterol 5:23-34. 2012
    ..pylori) infection (proton pump inhibitor-clarithromycin-amoxicillin) can easily be converted to non-bismuth quadruple (concomitant) therapy by the addition of a nitroimidazole twice daily...
  62. pmc Helicobacter Pylori "Test-and-Treat" Strategy for Management of Dyspepsia: A Comprehensive Review
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    Clin Transl Gastroenterol 4:e32. 2013
    ..The aim present article addresses the test-and-treat strategy and attempts to provide practical conclusions for the clinician who diagnoses and treats patients with dyspepsia...
  63. ncbi Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Instituto de Investigación Sanitaria Princesa IP, Playa de Mojácar 29 Urb Bonanza, 28669, Boadilla del Monte, Madrid, Spain
    Dig Dis Sci 59:383-9. 2014
    ..Helicobacter pylori eradication therapy with a proton pump inhibitor (PPI), clarithromycin, and amoxicillin fails in >20 % of cases. A rescue therapy with PPI-amoxicillin-levofloxacin still fails in >20 % of patients...
  64. doi Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain
    Am J Gastroenterol 108:1426-38. 2013
    ..However, data regarding their safety during pregnancy and breastfeeding are scarce. The aim of this study was to critically review available data on the safety of anti-TNF therapy during pregnancy and breastfeeding in women with IBD...
  65. doi Vaccination strategies in patients with IBD
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Diego de Leon 62, Madrid 28006, Spain
    Nat Rev Gastroenterol Hepatol 10:277-85. 2013
    ..Therefore, vaccination status should be checked and updated upon diagnosis of IBD...
  66. ncbi Pathophysiological bases of eosinophilic esophagitis therapy
    Ricardo Moreno-Borque
    Alergología Clínica Servicio de Medicina Interna, Hospital Rey Juan Carlos I, Mostoles, Madrid, Spain
    Inflamm Allergy Drug Targets 12:46-53. 2013
    ..Prolonged treatment is advised for EoE because it recurs frequently, particularly on discontinuation of therapy. Experimental treatments using immunotherapy are being investigated, but their safety and efficacy are yet to be defined...
  67. doi [Helicobacter pylori-related diseases]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain
    Gastroenterol Hepatol 35:12-25. 2012
    ..Even after three eradication therapies have failed, an empirical rescue therapy (with rifabutin) can be effective. H. pylori reinfection is highly frequent in developing countries, probably due to intrafamilial transmission...
  68. doi Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding
    J P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain
    Am J Gastroenterol 107:1197-204. 2012
    ..To evaluate the effect of Helicobacter pylori (H. pylori) eradication on ulcer bleeding recurrence in a prospective, long-term study including 1,000 patients...
  69. doi [Helicobacter pylori-related diseases: dyspepsia, ulcers and gastric cancer]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de Princesa, Instituto de Investigación Sanitaria Princesa IP, Madrid, Espana
    Gastroenterol Hepatol 34:15-26. 2011
    ..Even after three previous H. pylori eradication failures, an empirical fourth-line rescue treatment with rifabutin may be effective...
  70. doi Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough
    J P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP y Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    Aliment Pharmacol Ther 34:1255-68. 2011
    ..Therefore, it is evident that new strategies to improve first-line treatment are urgently needed...
  71. ncbi Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain
    Eur J Gastroenterol Hepatol 16:89-99. 2004
    ....
  72. ncbi [Role of biological markers in inflammatory bowel disease]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Espana
    Gastroenterol Hepatol 30:117-29. 2007
    ..Like calprotectin, fecal lactoferrin is also quantified by a simple and inexpensive ELISA method, although there is considerably less experience with this latter marker...
  73. pmc Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de Princesa, Madrid, Spain, and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Spain
    Health Qual Life Outcomes 7:60. 2009
    ..We report the burden of GERD in a large population of patients managed in primary care, in terms of symptoms and impact on patients' daily lives...
  74. ncbi Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    Dig Liver Dis 42:287-90. 2010
    ..To assess the efficacy and tolerability of Helicobacter pylori first-line treatment (omeprazole-clarithromycin-metronidazole) and second-line rescue option (omeprazole-clarithromycin-levofloxacin) in patients allergic to penicillin...
  75. doi Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: a real-life survey in Spain
    J P Gisbert
    Departamento de Gastroenterologia, Hospital Universitario La Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Spain
    J Crohns Colitis 4:567-74. 2010
    ..This knowledge would allow the local evaluation of the situation and the adoption of actions to reduce the existent clinical variability...
  76. ncbi Systematic review: Infliximab therapy in ulcerative colitis
    J P Gisbert
    Gastroenterology Unit, La Princesa University Hospital, Autonomous University, Madrid, Spain
    Aliment Pharmacol Ther 25:19-37. 2007
    ..To perform a systematic review and meta-analysis on the efficacy and tolerance of infliximab in ulcerative colitis...
  77. ncbi [Monitoring of thiopurine methyltransferase and thiopurine metabolites to optimize azathioprine therapy in inflammatory bowel disease]
    Javier P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de La Princesa Universidad Autónoma Madrid España
    Gastroenterol Hepatol 29:568-83. 2006
    ....
  78. ncbi Management of gastro-oesophageal reflux disease in primary care: a European observational study
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, C Diego de Leon 62, Madrid, Spain
    Curr Med Res Opin 25:2777-84. 2009
    ..To describe the management of gastro-oesophageal reflux disease (GERD) in primary care, as part of the RANGE (Retrospective ANalysis of GERD) study...
  79. ncbi [Helicobacter pylori-related diseases: dyspepsia, ulcer and gastric cancer]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Espana
    Gastroenterol Hepatol 31:18-28. 2008
    ..The annual recurrence rate of H. pylori infection is approximately 3% in developed countries and is higher than 10% in developing countries...
  80. ncbi Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease
    J P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigacion Sanitaria, Princesa IP, Madrid, Spain
    Aliment Pharmacol Ther 33:619-33. 2011
    ..Viral hepatitis is a very common infection...
  81. doi Sequential therapy for Helicobacter pylori eradication: a critical review
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    J Clin Gastroenterol 44:313-25. 2010
    ..Alternative treatment regimens for standard triple therapy are urgently needed...
  82. pmc Second-line rescue therapy of helicobacter pylori infection
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    Therap Adv Gastroenterol 2:331-56. 2009
    ..Therefore, the attitude in H. pylori eradication therapy failure, even after two or more unsuccessful attempts, should be to fight and not to surrender...
  83. ncbi Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    Inflamm Bowel Dis 15:1746-54. 2009
    ..Finally, in patients with Crohn's disease who have undergone ileocolonic resection, those with higher lactoferrin fecal levels might be more prone to postsurgical recurrence...
  84. doi Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    Aliment Pharmacol Ther 34:1047-62. 2011
    ..Helicobacter pylori infection is the main cause of gastric mucosa-associated lymphoid tissue (MALT) lymphoma...
  85. doi Consultation rates and characteristics of gastro-oesophageal reflux disease in primary care: a European observational study
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Madrid, Spain
    Eur J Gen Pract 15:154-60. 2009
    ..To report on the primary care consultation rates and clinical characteristics of patients with gastro-oesophageal reflux disease (GERD) as part of the RANGE (Retrospective ANalysis of GERD) observational study...
  86. ncbi Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Madrid, Spain
    Aliment Pharmacol Ther 30:126-37. 2009
    ..Debate exists regarding to whether thiopurine therapy is as effective in ulcerative colitis (UC) as it is in Crohn's disease...
  87. ncbi Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Ciberehd, Universidad Autonoma, Madrid, Spain
    Aliment Pharmacol Ther 27:346-54. 2008
    ..Several 'rescue' therapies have been recommended to eradicate Helicobacter pylori, but they still fail in >20% of the cases, and these patients constitute a therapeutic dilemma...
  88. pmc "Rescue" regimens after Helicobacter pylori treatment failure
    Javier P Gisbert
    Gastroenterology Unit, Hospital de la Princesa, Madrid, Spain
    World J Gastroenterol 14:5385-402. 2008
    ..Therefore, the attitude in H pylori eradication therapy failure, even after two or more unsuccessful attempts, should be to fight and not to surrender...
  89. ncbi Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding
    Javier P Gisbert
    Department of Gastroenterology, Hospital de la Princesa, Madrid, Spain
    Helicobacter 12:279-86. 2007
    ..To evaluate the effect of Helicobacter pylori eradication on ulcer bleeding recurrence in a prospective, long-term study including more than 400 patients...
  90. pmc Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Madrid, Spain
    Health Qual Life Outcomes 7:90. 2009
    ..This subanalysis of RANGE determined the impact of GERD on productivity in work and daily life...
  91. doi Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    Inflamm Bowel Dis 15:1190-8. 2009
    ....
  92. ncbi Clinical trial evaluating amoxicillin and clarithromycin hydrogels (Chitosan-polyacrylic acid polyionic complex) for H. pylori eradication
    Javier P Gisbert
    Gastroenterology Unit, La Princesa University Hospital, Autonomous University, School of Pharmacy, Alcala de Henares University, Alcala de Henares, Spain
    J Clin Gastroenterol 40:618-22. 2006
    ..This could be achieved by allowing the drug to remain longer in the stomach using dried hydrogels. Our aim was to evaluate the efficacy of an H. pylori eradication regimen including both amoxicillin and clarithromycin hydrogels...
  93. ncbi Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Playa de Mojácar 29, Urb Bonanza, 28669 Boadilla del Monte, Madrid, Spain
    Aliment Pharmacol Ther 16:1047-57. 2002
    ..Recently, rifabutin-based rescue therapies have been shown to constitute an encouraging strategy for eradication failures, as they are effective against H. pylori strains resistant to antibiotics...
  94. ncbi Helicobacter pylori infection, gastric metaplasia in the duodenum and the relationship with ulcer recurrence
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Eur J Gastroenterol Hepatol 12:1295-8. 2000
    ..pylori) infection and gastric metaplasia (GM) in the duodenum a large group of patients with duodenal ulcer was evaluated to determine whether these factors are related to the number of ulcer recurrences...
  95. ncbi [Cyclooxygenase-2 and gastroduodenal lesions. Any relationship with Helicobacter pylori ? A systematic review]
    Javier P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de La Princesa Madrid España
    Med Clin (Barc) 120:550-8. 2003
  96. ncbi [The role of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease]
    J P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de La Princesa Madrid Spain
    Gastroenterol Hepatol 26:312-24. 2003
  97. ncbi [Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine]
    Javier P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de la Princesa Universidad Autónoma Madrid Spain
    Med Clin (Barc) 121:1-5. 2003
    ....
  98. ncbi Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis
    Javier P Gisbert
    Servicio de Gastroenterología y Hepatología, Universidad Autonoma de Madrid, Hospital Universitario de la Princesa, Diego de Leon, 62 28006, Madrid, Spain
    J Hepatol 39:620-7. 2003
    ..To conduct a systematic review and meta-analysis on the prevalence of hepatitis C virus (HCV) infection in porphyria cutanea tarda (PCT)...
  99. ncbi [Anti-neutrophil cytoplasmic antibodies in the diagnosis of ulcerative colitis and Crohn's disease]
    Javier P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de La Princesa Madrid España
    Med Clin (Barc) 122:134-5. 2004
    ..We assessed the prevalence and diagnostic value of antineutrophil cytoplasmic antibodies (ANCA) with a perinuclear pattern (pANCA) in patients with Crohn's disease (CD) and ulcerative colitis (UC)...
  100. ncbi [Systematic reviews and meta-analyses: how should they be performed, evaluated and used?]
    J P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Spain
    Gastroenterol Hepatol 27:129-49. 2004
  101. ncbi Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Playa de Mojácar 29, Urb Bonanza, 28669 Boadilla del Monte, Madrid, Spain
    Dig Liver Dis 36:116-20. 2004
    ....